Virological and clinical characteristics of delta hepatitis in Central Europe.
about
Hepatitis B and Delta Virus: Advances on Studies about Interactions between the Two Viruses and the Infected HepatocyteDevelopment and evaluation of a baseline-event-anticipation score for hepatitis deltaReplicative and transcriptional activities of hepatitis B virus in patients coinfected with hepatitis B and hepatitis delta viruses.High prevalence and predominance of hepatitis delta virus genotype 1 infection in CameroonEpidemiological, clinical and histological characteristics of HBV/HDV co-infection: a retrospective cross-sectional study in Guangdong, ChinaVirological and clinical characteristics of hepatitis delta virus in South Asia.Clinical Features and Seroepidemiology of Anti-HDV Antibody in patients With Chronic Hepatitis B Virus Infection in Iran: A Meta-Analysis.A prominent role of Hepatitis D Virus in liver cancers documented in Central Africa.Hepatitis D Virus Infection Among Hepatitis B Surface Antigen Carriers and in "Isolated anti-HBc" Antibodies Profile in Central Tunisia.Hepatitis D Virus: A Call to Screening.Serological and molecular diagnosis of hepatitis delta virus infection: results of a French national quality control study.Animal models of chronic hepatitis delta virus infection host-virus immunologic interactions.Hepatitis Delta Virus: Replication Strategy and Upcoming Therapeutic Options for a Neglected Human Pathogen.Treatment options for hepatitis delta virus infection.Unsolved Puzzles Surrounding HCV Immunity: Heterologous Immunity Adds Another Dimension.Performance Characteristics of a New Consensus Commercial Kit for Hepatitis D Virus RNA Viral Load Quantification.Antiviral treatment and liver-related complications in hepatitis delta.Establishment of a novel quantitative hepatitis D virus (HDV) RNA assay using the Cobas TaqMan platform to study HDV RNA kineticsChanging hepatitis D virus epidemiology in a hepatitis B virus endemic area with a national vaccination program.Recent advances in managing hepatitis DHepatitis B virus surface antigen and anti-hepatitis C virus rapid tests underestimate hepatitis prevalence among HIV-infected patients.Late HDV RNA relapse after peginterferon alpha-based therapy of chronic hepatitis delta.Coinfection of hepatitis B and hepatitis delta virus in Belgium: a multicenter BASL study. Prospective epidemiology and comparison with HBV mono-infection.The role of HBsAg levels in the current management of chronic HBV infection.Chronic hepatitis D at a standstill: where do we go from here?The diversity of chronic hepatitis B virus infections within blood donors in England and North Wales 2005 through 2010.Prevalence and clinical significance of hepatitis D virus co-infection in patients with chronic hepatitis B in Korea.Prevalence of hepatitis delta virus (HDV) infection in chronic hepatitis B patients in eastern Turkey: still a serious problem to consider.Clinical outcome of acute and chronic hepatitis delta over time: a long-term follow-up studyCurrent Concept in the Pathophysiology of Hepatitis Delta Infection
P2860
Q26775635-069EFC11-8484-492E-A5F5-267EC0BF327BQ33414249-741F2EB3-A916-4E4E-A32F-AD4F727CCD03Q34457758-2E891D68-8008-48FC-9476-8E11D4ADDE4EQ34741403-5C003F3D-DED9-458F-97B4-FF2B8A502D35Q34757956-67EEA315-A9D1-4367-9600-F61D48C5DB42Q35111441-53EA46ED-ED65-4BB1-B92E-1079951A2F95Q35764198-0792D824-2C08-45D8-BA72-F6BD47DCD8CEQ36184624-0A4ACB97-AD1C-47E8-9DA4-95B719C9D65AQ36805902-258B691F-1BCC-4C68-B896-C710C4D61630Q37182821-8146FD1C-1ADE-43F1-9370-3EA41B6CDC10Q37713672-D2A649DC-5C7A-4AC1-8164-9DCF206F4A51Q38357110-679AD74D-26FE-4369-A643-CD9E3CD88CF8Q39414876-104018CD-6FF2-437F-9A90-D2BB72F13EC2Q39502937-E89F151E-14AC-4ABE-ACCD-2627259C7ACEQ40106073-CFCEEC53-2ED1-4578-A132-29D3746637C0Q40437975-622F3581-2149-4207-9C5A-43AA431931B2Q40492331-AC45E632-8958-4023-AF12-382DF59D7311Q41015358-CC9B94BD-95A3-4980-A102-137A56BC8857Q41441778-EE12DCF4-C0B3-4603-ADA6-94950E481157Q41588940-514C6AE6-43D0-4094-B847-A1056CE54E1DQ42220089-0A29BE56-729F-429D-A33F-3EF64E2D4599Q42234354-19B9B9DC-584A-41BF-BD1E-7EF1BDDE40BCQ42283907-9C9A937D-9A83-45A5-B307-B5FAC00E6D08Q42360905-61489778-851A-4E03-A656-81F18B873F4AQ43492653-AFC81C2D-ECF5-4DBF-A610-CFD2A6548B12Q43998760-8FEB80BE-8C8A-4255-8744-24A284E95FDDQ45366842-A5FA766E-7B31-4801-B6BC-518273626BAEQ45375325-B7C953A3-049C-4916-BDF9-DE4081D44B77Q57097288-442D9AB0-73B2-4B2E-BC25-6B9B35231506Q58945256-25A5232A-0A94-4F0D-958A-1F249C3D960C
P2860
Virological and clinical characteristics of delta hepatitis in Central Europe.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Virological and clinical characteristics of delta hepatitis in Central Europe.
@en
Virological and clinical characteristics of delta hepatitis in Central Europe.
@nl
type
label
Virological and clinical characteristics of delta hepatitis in Central Europe.
@en
Virological and clinical characteristics of delta hepatitis in Central Europe.
@nl
prefLabel
Virological and clinical characteristics of delta hepatitis in Central Europe.
@en
Virological and clinical characteristics of delta hepatitis in Central Europe.
@nl
P2093
P1476
Virological and clinical characteristics of delta hepatitis in Central Europe.
@en
P2093
B Heidrich
H L Tillmann
H Wedemeyer
K Deterding
P304
P356
10.1111/J.1365-2893.2009.01144.X
P577
2009-06-28T00:00:00Z